Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lamarche

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
Nature Immunology|April 20, 2023
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancerMatthew D Park, Ivan Reyes-Torres, Jessica LeBerichel, et al.
Science (New York, N.Y.)|September 5, 2024
Hematopoietic aging promotes cancer by fueling IL-1⍺-driven emergency myelopoiesisMatthew D Park, Jessica Le Berichel, Pauline Hamon, et al.
Nature|December 6, 2023
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesisNelson M LaMarche, Samarth Hegde, Matthew D Park, et al.
Nature Medicine|January 27, 2026
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockadeEdgar Gonzalez-Kozlova, Robert Sweeney, Igor Figueiredo, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Nature Immunology|April 20, 2023
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancerMatthew D Park, Ivan Reyes-Torres, Jessica LeBerichel, et al.
Science (New York, N.Y.)|September 5, 2024
Hematopoietic aging promotes cancer by fueling IL-1⍺-driven emergency myelopoiesisMatthew D Park, Jessica Le Berichel, Pauline Hamon, et al.
Nature|December 6, 2023
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesisNelson M LaMarche, Samarth Hegde, Matthew D Park, et al.
Nature Medicine|January 27, 2026
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockadeEdgar Gonzalez-Kozlova, Robert Sweeney, Igor Figueiredo, et al.
Pageof 12